-
Marcolina S. Cholesterol- and glucose-lowering effects of fenugreek. Altern Med Alert 2004;7(12):136-139.
-
O'Mathuna DP. Low-carbohydrate diets and weight loss. Altern Med Alert 2004;7(12):133-136.
-
Prostate Cancer Among Men with a Prostate- Specific Antigen Level < 4.0 ng/mL; Mirtazapine for Reducing Nocturnal Itch in Patients with Chronic Pruritus; Interventions for the Prevention of Postoperative Nausea and Vomiting; Multivitamin Supplements and HIV Disease Progression and Mortality; The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study; Trial of Atorvastatin in Rheumatoid Arthritis (TARA).
-
Prevalence of Prostate Cancer Among Men with a Prostate-Specific Antigen Level < 4.0 ng/mL; Mirtazapine for Reducing Nocturnal Itch in Patients with Chronic Pruritus; A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
-
A new quaternary ammonium compound has been approved for the treatment of overactive bladder.
-
A carbapenem (most often imipenem) was found in a prospective observational study to be the optimal choice for therapy of bacteremia due to ESBL-producing Klebsiella pneumoniae.
-
An outbreak of food poisoning by Yersinia pseudotuberculosis<?I> in Finland in October/November1998 involved 46 cases and was traced to locally grown iceberg lettuce.
-
Molecular techniques provide a more rapid and accurate method of Nocardia species identification than do classical microbiologic methods. A surprise: of 94 isolates, the most commonly identified species was Nocardia cyriacigeorgica and none were Nocardia asteroides.
-
A laboratory report indicating susceptibility of MRSA to vancomycin does not guarantee successful therapy with this antibiotic since a significant risk for failure may be present despite MICs within the range considered susceptible.
-
According to AGI's study, contraceptive coverage improved dramatically between 1993 and 2002 among health plans purchased by employers for their employees.In 2001 and 2002, AGI researchers surveyed insurance companies across the nation, asking whether prescription contraceptives and other comparable drugs, devices, and services were covered in the "typical" managed care plans they wrote for their employers.